C. Christa

发表

Long-term follow-up of SARS-CoV-2 convalescents reveals distinct magnitude of spike-specific immunity after viral re-exposure and vaccination

E. Vogel, P. Knolle, H. Roggendorf, 2021 .

Dynamics of humoral and cellular immune responses after homologous and heterologous SARS-CoV-2 vaccination with ChAdOx1 nCoV-19 and BNT162b2

K. Überla, B. Liao, C. Bogdan, 2022, eBioMedicine.

Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concern

H. Blum, K. Überla, V. Hornung, 2022, Nature Medicine.

Automated detection of neutralizing SARS-CoV-2 antibodies in minutes using a competitive chemiluminescence immunoassay

M. Seidel, P. Knolle, U. Protzer, 2022, Analytical and Bioanalytical Chemistry.

Dynamics of spike-and nucleocapsid specific immunity during long-term follow-up and vaccination of SARS-CoV-2 convalescents

J. Ruland, P. Knolle, H. Roggendorf, 2022, Nature communications.

RBD-Based ELISA and Luminex Predict Anti-SARS-CoV-2 Surrogate-Neutralizing Activity in Two Longitudinal Cohorts of German and Spanish Health Care Workers

D. Busch, A. Angulo, E. Soutschek, 2023, Microbiology spectrum.

Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2

K. Überla, C. Bogdan, J. Mattner, 2021, The Lancet Infectious Diseases.

Determinants for detection of infection with SARS-CoV-2 Omicron variants of concern in health care workers by rapid antigen tests

U. Protzer, P. Knolle, J. Wettengel, 2022, medRxiv.

Comparable cellular and humoral immunity upon homologous and heterologous COVID-19 vaccination regimens in kidney transplant recipients

V. Assfalg, U. Protzer, H. Mijočević, 2023, Frontiers in Immunology.

Improved SARS-CoV-2 Neutralization of Delta and Omicron BA.1 Variants of Concern after Fourth Vaccination in Hemodialysis Patients

L. Renders, U. Heemann, U. Protzer, 2022, medRxiv.

Longitudinal SARS-CoV-2 neutralization of Omicron BA.1, BA.5 and BQ.1.1 after four vaccinations and the impact of break-through infections in hemodialysis patients

U. Protzer, O. Keppler, C. Kuechle, 2023, medRxiv.

SARS-CoV-2 Neutralization Capacity in Hemodialysis Patients with and without a Fifth Vaccination with the Updated Comirnaty Original/Omicron BA.4-5 Vaccine

C. Schmaderer, M. Braunisch, C. Christa, 2024, Vaccines.

Clinical and immunological benefits of full primary COVID-19 vaccination in individuals with SARS-CoV-2 breakthrough infections: A prospective cohort study in non-hospitalized adults.

T. Wibmer, Raquel Rubio Acero, H. Roggendorf, 2023, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.